In contrast to the pathogenic role of IL-1 and IL-18 in atherosclerosis pathogenesis, IL-33 has been described to attenuate cardiovascular inflammation and plaque formation (Miller et al., 2008). The gene discussed is IL1A; the disease is atherosclerosis.